Institutional Ownership Alx Oncology Holdings Inc (ALXO)
This table provides information about the institutional ownership of Alx Oncology Holdings Inc (ALXO). We have compiled data on the 91 institutions that hold shares in the stock, with a total of 35.3 Million shares, which have been reported (via 13F filing form) to have a value of $17.3 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ven Bio Partners LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
9,699,925
shares
|
$4.66 Million
6.44% of portfolio
|
Q3 2020
New holding
|
|
|
Redmile Group, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
3,640,834
shares
|
$1.75 Million
0.24% of portfolio
|
Q1 2025
Reduced 1.32%
|
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
3,158,265
shares
|
$1.52 Million
0.13% of portfolio
|
Q1 2025
Reduced 4.2%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,687,619
shares
|
$1.29 Million
0.0% of portfolio
|
Q2 2024
Added 20.98%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
1,837,923
shares
|
$882,203
0.0% of portfolio
|
Q1 2025
Reduced 2.6%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
1,451,778
shares
|
$696,853
0.0% of portfolio
|
Q1 2025
Added 40.22%
|
|
|
Almitas Capital LLC
Santa Monica, CA |
May 15, 2025 Q1 2025 |
1,353,141
shares
|
$649,507
0.47% of portfolio
|
Q1 2025
Added 10.65%
|
|
|
Acadian Asset Management LLC
Boston, MA |
May 21, 2025 Q1 2025 |
1,296,331
shares
|
$622,238
0.0% of portfolio
|
Q1 2025
Added 16.84%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
944,084
shares
|
$453,160
0.0% of portfolio
|
Q1 2025
Reduced 55.66%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
770,907
shares
|
$370,035
0.0% of portfolio
|
Q1 2025
Added 4.16%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
718,853
shares
|
$345,049
0.0% of portfolio
|
Q1 2025
Added 5.08%
|
|
|
Bank Of Montreal
Toronto, A6 |
May 13, 2025 Q1 2025 |
682,394
shares
|
$327,549
0.0% of portfolio
|
Q1 2025
Reduced 17.44%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
681,000
shares
|
$326,880
0.0% of portfolio
|
Q1 2025
Reduced 17.34%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2025 Q1 2025 |
550,000
shares
|
$264,000
0.06% of portfolio
|
Q1 2025
Reduced 60.47%
|
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
542,655
shares
|
$260,474
0.0% of portfolio
|
Q1 2025
Reduced 22.93%
|
|
|
Privium Fund Management B.V.
|
May 08, 2025 Q1 2025 |
509,059
shares
|
$244,348
0.08% of portfolio
|
Q3 2024
Added 28.24%
|
|
|
Los Angeles Capital Management LLC
|
May 05, 2025 Q1 2025 |
409,938
shares
|
$196,770
0.0% of portfolio
|
Q1 2025
Added 36.0%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
373,214
shares
|
$179,142
0.0% of portfolio
|
Q1 2025
Reduced 34.41%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
358,460
shares
|
$172,060
0.0% of portfolio
|
Q1 2025
Reduced 85.66%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
357,957
shares
|
$171,819
0.0% of portfolio
|
Q1 2025
Added 51.65%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
318,183
shares
|
$152,727
0.0% of portfolio
|
Q1 2025
Reduced 7.25%
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
271,197
shares
|
$130,174
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
256,493
shares
|
$123,116
0.0% of portfolio
|
Q1 2025
Reduced 37.14%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
211,051
shares
|
$101,304
0.0% of portfolio
|
Q1 2025
Reduced 2.61%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
164,790
shares
|
$79,099
0.0% of portfolio
|
Q4 2024
Added 55.62%
|